K'Watch Glucose

Press Releases

PKvitality announces the results of its 3rd clinical trial on humans

 The French startup PKvitality, focusing on health and sport biowearables, is developing K’Watch Glucose, the first Continuous Glucose Monitor (CGM) in the form of a smartwatch, designed to change the daily lives of millions of diabetic patients. After two first phases of testing which brought a significant step forward on the initial roadmap, the company champion of innovation against diabetes announces the results of its third phase of clinical trials on humans…